The present invention relates to a pharmaceutical preparation for theprophylaxis and treatment of critical illnesspolyneuropathy (CIP) and critical illness myopathy (CIM). The inventionfurther relates to an isotonic fat emulsion comprising atleast one triglyceride that comprises at least one fatty acid group having anodd number of carbon atoms, wherein the fatty acidgroup comprises a carbon chain having 5 to 15 carbon atoms.